June Investor Update
Investor Presentation
Forward-Looking Statements and Non-GAAP Financial Measures
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the
The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:
• |
difficult conditions in global capital markets and the economy, including those caused by COVID-19 |
• |
subsidiaries' ability to pay dividends to the Parent Company |
• |
defaults and credit downgrades of investments |
• |
inherent limitations to risk management policies and procedures |
• |
exposure to significant interest rate risk |
• |
the level of sales of |
• |
concentration of business in |
• |
tax rates applicable to the Company may change |
• |
limited availability of acceptable yen-denominated investments |
• |
failure to comply with restrictions on policyholder privacy and information security |
• |
foreign currency fluctuations in the yen/dollar exchange rate |
• |
extensive regulation and changes in law or regulation by governmental authorities |
• |
differing judgments applied to investment valuations |
• |
competitive environment and ability to anticipate and respond to market trends |
• |
significant valuation judgments in determination of expected credit losses recorded on the Company's investments |
• |
catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics |
• |
decreases in the Company's financial strength or debt ratings |
(such as the coronavirus COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military |
|
• |
decline in creditworthiness of other financial institutions |
action, terrorism or other acts of violence, and damage incidental to such events |
|
• |
concentration of the Company's investments in any particular single-issuer or sector |
• |
ability to protect the Aflac brand and the Company's reputation |
• |
the effects of COVID-19 and its variants (both known and emerging), and any resulting economic effects and government• |
ability to effectively manage key executive succession |
|
• |
interventions, on the Company's business and financial results |
• |
changes in accounting standards |
the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners |
• |
level and outcome of litigation |
|
• |
deviations in actual experience from pricing and reserving assumptions |
• |
allegations or determinations of worker misclassification in |
- ability to continue to develop and implement improvements in information technology systems
- interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems
Non-
This document includes references to the Company's financial performance measures which are not calculated in accordance with
Definitions of the Company's non-
Due to the size of
2
Segment Overview
Aflac Japan Business Profile
Aflac Japan insures1 in 4 households1 inJapan and is the #1 cancer and medical insurer2.- Our corethird sector insurance - cancer and medical - helps policyholders cover out-of-pocket expenses not covered by Japan's national health insurance system.
Aflac Japan's third sector product portfolio is complemented by a select offering offirst sector protection products.Aflac Japan's goal is to be the leading company for "living in your own way."
2021 Net Earned Premiums
Aflac
- Aflac is the leading supplemental health insurer in the
U.S. - Aflac's supplemental policiespay cash directly to the insured to help protect against rising out-of-pocket expenses when a qualifying medical event occurs.
- Aflac
U.S.'s vision is to seek to further develop "a world where people are better prepared for unexpected health expenses."
2021 Net Earned Premiums
Third
Sector
Medical and other health29%
29%
Cancer 22%Life
49% insurance
22%
Cancer 22%
Other health
27%
Accident / disability 45%
Life
insurance
6%
1 Based on the 2020 number of households published by Japan's |
3 |
2 Aflac is the number one insurer in terms of the total combined number of cancer insurance and medical insurance policies in force, according to Statistics of Life Insurance Business in |
Japan 2020.
2021 Highlights
Cash |
Share |
Dividend |
Repurchase |
+17.9% |
|
EPS |
Adjusted EPS* |
-4.2% |
+19.8% |
ROE |
Adjusted ROE* |
12.9% |
15.9% |
- Our strategic focus:
-
- Navigating the pandemic in a strong financial condition
- Executing on key growth and efficiency initiatives
- Returning capital to shareholders - Dividend increased ~43% since 2020
- Driving ESG initiatives across the enterprise
*Non-GAAP measure; please see Appendix for definitions and reconciliations.
4
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer
Car Insurance Market to See Booming Growth : Allstate Insurance, Metlife, State Farm Insurance
$100 million legal bill in Surfside condo suit. Court filing argues it’s a bargain [Miami Herald]
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News